The University of Chicago Header Logo

Connection

Neil Sengupta to Biological Products

Back to Details
This is a "connection" page, showing publications Neil Sengupta has written about Biological Products.
Neil Sengupta
Connection Strength
0.158
Biological Products
  1. Comparative Efficacy and Rapidity of Action for Infliximab vs Ustekinumab in Biologic Naïve Crohn's Disease. Clin Gastroenterol Hepatol. 2022 07; 20(7):1579-1587.e2.
    View in: PubMed
    Score: 0.158
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.